109 related articles for article (PubMed ID: 16408863)
1. Adsorption of meloxicam on porous calcium silicate: characterization and tablet formulation.
Sharma S; Sher P; Badve S; Pawar AP
AAPS PharmSciTech; 2005 Dec; 6(4):E618-25. PubMed ID: 16408863
[TBL] [Abstract][Full Text] [Related]
2. Low density multiparticulate system for pulsatile release of meloxicam.
Sharma S; Pawar A
Int J Pharm; 2006 Apr; 313(1-2):150-8. PubMed ID: 16540268
[TBL] [Abstract][Full Text] [Related]
3. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
Ghorab MM; Abdel-Salam HM; El-Sayad MA; Mekhel MM
AAPS PharmSciTech; 2004 Jul; 5(4):e59. PubMed ID: 15760056
[TBL] [Abstract][Full Text] [Related]
4. Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate.
Kinoshita M; Baba K; Nagayasu A; Yamabe K; Shimooka T; Takeichi Y; Azuma M; Houchi H; Minakuchi K
J Pharm Sci; 2002 Feb; 91(2):362-70. PubMed ID: 11835196
[TBL] [Abstract][Full Text] [Related]
5. Reduction of tablet coloration at tableting for oily medicine (tocopheryl nicotinate).
Takashima Y; Yuasa H; Kanaya Y; Nomura I; Shinozawa K
Int J Pharm; 1999 Sep; 187(1):125-35. PubMed ID: 10502619
[TBL] [Abstract][Full Text] [Related]
6. Adsorption of a poorly water-soluble drug onto porous calcium silicate by the sealed heating method.
Kawano Y; Chen S; Hanawa T
Int J Pharm; 2020 Sep; 587():119637. PubMed ID: 32663587
[TBL] [Abstract][Full Text] [Related]
7. A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design.
Aboelwafa AA; Fahmy RH
Pharm Dev Technol; 2012; 17(1):1-14. PubMed ID: 20550483
[TBL] [Abstract][Full Text] [Related]
8. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
Dehghani H; Taheri A; Homayouni A
Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of NIR-chemometric methods for chemical and pharmaceutical characterization of meloxicam tablets.
Tomuta I; Iovanov R; Bodoki E; Vonica L
Drug Dev Ind Pharm; 2014 Apr; 40(4):549-59. PubMed ID: 23594301
[TBL] [Abstract][Full Text] [Related]
10. Improvement of the agitation granulation method to prepare granules containing a high content of a very hygroscopic drug.
Hirai N; Ishikawa K; Takahashi K
J Pharm Pharmacol; 2006 Nov; 58(11):1437-41. PubMed ID: 17132205
[TBL] [Abstract][Full Text] [Related]
11. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems.
Nalluri BN; Chowdary KP; Murthy KV; Becket G; Crooks PA
AAPS PharmSciTech; 2007 May; 8(2):Article 36. PubMed ID: 17622114
[TBL] [Abstract][Full Text] [Related]
12. Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate.
Yuasa H; Asahi D; Takashima Y; Kanaya Y; Shinozawa K
Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2327-31. PubMed ID: 7859331
[TBL] [Abstract][Full Text] [Related]
13. Highly stabilized amorphous 3-bis(4-methoxyphenyl)methylene-2-indolinone (TAS-301) in melt-adsorbed products with silicate compounds.
Kinoshita M; Baba K; Nagayasu A; Yamabe K; Azuma M; Houchi H; Minakuchi K
Drug Dev Ind Pharm; 2003 May; 29(5):523-9. PubMed ID: 12779282
[TBL] [Abstract][Full Text] [Related]
14. Dissolution studies and quantification of meloxicam in tablet dosage form by spectrophotometry.
Induri M; Mantripragada BR; Yejella RP; Kunda PR; Nannapaneni DT; Boddu R
Pak J Pharm Sci; 2012 Jan; 25(1):283-7. PubMed ID: 22186342
[TBL] [Abstract][Full Text] [Related]
15. Preparation and evaluation of an orally fast disintegrating tablet formulation containing a hydrophobic drug.
Comoglu T; Unal B
Pharm Dev Technol; 2015 Jan; 20(1):60-4. PubMed ID: 24295202
[TBL] [Abstract][Full Text] [Related]
16. Preparation and Evaluation of Solid Dispersion Tablets by a Simple and Manufacturable Wet Granulation Method Using Porous Calcium Silicate.
Fujimoto Y; Hirai N; Takatani-Nakase T; Takahashi K
Chem Pharm Bull (Tokyo); 2016; 64(4):311-8. PubMed ID: 27039831
[TBL] [Abstract][Full Text] [Related]
17. Tablet preformulations of indomethacin-loaded mesoporous silicon microparticles.
Tahvanainen M; Rotko T; Mäkilä E; Santos HA; Neves D; Laaksonen T; Kallonen A; Hämäläinen K; Peura M; Serimaa R; Salonen J; Hirvonen J; Peltonen L
Int J Pharm; 2012 Jan; 422(1-2):125-31. PubMed ID: 22063301
[TBL] [Abstract][Full Text] [Related]
18. Drug loading into porous calcium carbonate microparticles by solvent evaporation.
Preisig D; Haid D; Varum FJ; Bravo R; Alles R; Huwyler J; Puchkov M
Eur J Pharm Biopharm; 2014 Aug; 87(3):548-58. PubMed ID: 24568926
[TBL] [Abstract][Full Text] [Related]
19. Electrochemical reduction of meloxicam at mercury electrode and its determination in tablets.
Beltagi AM; Ghoneim MM; Radi A
J Pharm Biomed Anal; 2002 Feb; 27(5):795-801. PubMed ID: 11814720
[TBL] [Abstract][Full Text] [Related]
20. Preformulation studies on solid self-emulsifying systems in powder form containing magnesium aluminometasilicate as porous carrier.
Krupa A; Szlęk J; Jany BR; Jachowicz R
AAPS PharmSciTech; 2015 Jun; 16(3):623-35. PubMed ID: 25501870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
